GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $748,000 | -18.4% | 17,191 | -18.4% | 0.00% | 0.0% |
Q1 2022 | $917,000 | -6.2% | 21,055 | -5.0% | 0.00% | 0.0% |
Q4 2021 | $978,000 | -15.7% | 22,171 | -27.0% | 0.00% | -20.0% |
Q3 2021 | $1,160,000 | -3.7% | 30,369 | +0.4% | 0.01% | 0.0% |
Q2 2021 | $1,205,000 | -2.3% | 30,261 | -12.4% | 0.01% | -16.7% |
Q1 2021 | $1,233,000 | -11.0% | 34,535 | -8.2% | 0.01% | -14.3% |
Q4 2020 | $1,385,000 | -21.9% | 37,627 | -20.1% | 0.01% | -30.0% |
Q3 2020 | $1,773,000 | -32.8% | 47,104 | -27.2% | 0.01% | -37.5% |
Q2 2020 | $2,640,000 | -0.3% | 64,726 | -7.4% | 0.02% | -15.8% |
Q1 2020 | $2,649,000 | -23.9% | 69,924 | -5.5% | 0.02% | 0.0% |
Q4 2019 | $3,479,000 | +11.8% | 74,028 | +1.5% | 0.02% | 0.0% |
Q3 2019 | $3,112,000 | -7.0% | 72,910 | -12.8% | 0.02% | -5.0% |
Q2 2019 | $3,345,000 | -4.1% | 83,580 | +0.2% | 0.02% | -9.1% |
Q1 2019 | $3,487,000 | +12.1% | 83,450 | +2.5% | 0.02% | -4.3% |
Q4 2018 | $3,112,000 | -5.7% | 81,454 | -0.8% | 0.02% | +9.5% |
Q3 2018 | $3,299,000 | -9.1% | 82,116 | -8.8% | 0.02% | -16.0% |
Q2 2018 | $3,630,000 | -5.0% | 90,045 | -8.0% | 0.02% | -3.8% |
Q1 2018 | $3,823,000 | +4.0% | 97,860 | -5.5% | 0.03% | +4.0% |
Q4 2017 | $3,675,000 | -14.1% | 103,597 | -1.7% | 0.02% | -19.4% |
Q3 2017 | $4,277,000 | -0.2% | 105,350 | +6.0% | 0.03% | -3.1% |
Q2 2017 | $4,284,000 | +15.9% | 99,340 | +13.3% | 0.03% | +14.3% |
Q1 2017 | $3,695,000 | -1.3% | 87,644 | -9.9% | 0.03% | -6.7% |
Q4 2016 | $3,745,000 | -23.8% | 97,256 | -14.6% | 0.03% | -26.8% |
Q3 2016 | $4,914,000 | -3.4% | 113,945 | -3.0% | 0.04% | -4.7% |
Q2 2016 | $5,089,000 | +13.6% | 117,419 | +6.3% | 0.04% | +10.3% |
Q1 2016 | $4,478,000 | -0.6% | 110,442 | -1.1% | 0.04% | -2.5% |
Q4 2015 | $4,507,000 | -3.9% | 111,698 | -8.5% | 0.04% | -9.1% |
Q3 2015 | $4,692,000 | -5.9% | 122,039 | +1.9% | 0.04% | +2.3% |
Q2 2015 | $4,988,000 | +1.4% | 119,752 | +12.3% | 0.04% | 0.0% |
Q1 2015 | $4,921,000 | -22.5% | 106,624 | -28.2% | 0.04% | -20.4% |
Q4 2014 | $6,350,000 | -7.2% | 148,566 | -0.2% | 0.05% | -12.9% |
Q3 2014 | $6,844,000 | -12.8% | 148,881 | +1.5% | 0.06% | -12.7% |
Q2 2014 | $7,846,000 | +7.1% | 146,712 | +7.0% | 0.07% | +2.9% |
Q1 2014 | $7,328,000 | -2.2% | 137,151 | -2.2% | 0.07% | -4.2% |
Q4 2013 | $7,491,000 | +12.0% | 140,304 | +5.3% | 0.07% | +4.3% |
Q3 2013 | $6,688,000 | -0.2% | 133,303 | -0.6% | 0.07% | -4.2% |
Q2 2013 | $6,704,000 | – | 134,167 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |